Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
Taieb J, Le Malicot K, Shi Q, Penault-Llorca F, Bouché O, Tabernero J, Mini E, Goldberg RM, Folprecht G, Luc Van Laethem J, Sargent DJ, Alberts SR, Emile JF, Laurent Puig P, Sinicrope FA.
Taieb J, et al. Among authors: sinicrope fa.
J Natl Cancer Inst. 2016 Dec 31;109(5):djw272. doi: 10.1093/jnci/djw272. Print 2017 May.
J Natl Cancer Inst. 2016.
PMID: 28040692
Free PMC article.
Clinical Trial.